Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 23, 2019

SELL
$84.2 - $98.62 $7.11 Million - $8.32 Million
-84,400 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$80.14 - $106.07 $1.27 Million - $1.68 Million
15,800 Added 23.03%
84,400 $7.19 Million
Q3 2018

Nov 02, 2018

SELL
$93.92 - $105.72 $1.6 Million - $1.8 Million
-17,050 Reduced 19.91%
68,600 $6.65 Million
Q2 2018

Aug 01, 2018

BUY
$76.01 - $99.03 $6.51 Million - $8.48 Million
85,650 New
85,650 $8.07 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Decatur Capital Management, Inc. Portfolio

Follow Decatur Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Decatur Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Decatur Capital Management, Inc. with notifications on news.